In a significant portfolio adjustment, Cornerstone Planning Group has acquired a $12.5 million position in the VictoryShares Short-Term Bond ETF (USTB), signaling a strategic pivot towards capital preservation and income in anticipation of evolving monetary policy.
Luxury sleepwear brand Petite Plume names former Fleur du Mal president Irina Topuria to its newly created president role, tasking her with steering strategic growth and operational scaling as the company eyes broader market reach.
The strategic purchase of Meritage Portfolio Management adds nine advisors and deepens Captrust's presence in a competitive regional market, following its 2022 entry via Frontier Wealth Management.
Despite a five-year decline in earnings, Frontline plc (NYSE:FRO) shares have rallied sharply this week, buoyed by dividend growth and revenue increases, prompting a closer look at the metrics driving this apparent disconnect.
From 2 million to 20 million, the staggering range of estimates for the U.S. housing shortfall reveals a deeper debate over what constitutes a 'shortage' and how to fix an affordability crisis squeezing millions of families.
Boston Scientific reported robust Q4 and full-year 2025 results, with organic sales growth reaching the high end of guidance. The company provided a confident outlook for 2026, driven by strength in its Electrophysiology and WATCHMAN franchises, while addressing near-term headwinds in other segments.
Nathan Golik, a former NexCore Group executive, joins Ryan Cos. as President of its South Central region, bringing over $2 billion in development experience to steer the contractor's growing portfolio in Texas, Oklahoma, Louisiana, and Arkansas.
Taysha Gene Therapies has dosed the first patient in its pivotal REVEAL trial for TSHA-102 and secured FDA agreement to incorporate data from its earlier ASPIRE study into a future marketing application, marking a significant step in its quest to bring a treatment for Rett syndrome to market.
Shares of thermal management specialist Modine Manufacturing have more than doubled over the past year, fueled by data center cooling demand. As the stock trades near record highs, investors are weighing whether its premium valuation is justified by future growth prospects.
CNBC's Jim Cramer has singled out Agnico Eagle Mines as his top pick in the gold mining sector, emphasizing its high-quality reserves in politically secure regions like Canada as a critical hedge amid tightening global supply and rising instability.
Wabash National Corporation reported a challenging fourth quarter, with revenue and earnings falling short of expectations amid persistent softness in freight and industrial markets. While the company implemented cost-cutting measures, including facility idlings, its Parts & Services segment showed notable resilience, growing 33% year-over-year.
AppLovin's shares have faced significant pressure recently, declining roughly 25% over the past month and year-to-date. This slump contrasts sharply with its stellar long-term returns and blockbuster Q3 earnings, leaving investors to debate whether the stock is now undervalued or if growth concerns are justified.
The abrupt departure of HP CEO Enrique Lores to helm PayPal, coupled with a steep decline in shareholder returns, has thrown the spotlight on the PC and printer giant's strategic direction and current market valuation. Analysts are divided on whether the sell-off presents a buying opportunity or reflects deeper challenges.
Analysts at Jefferies have downgraded consumer health giant Kenvue to Hold, slashing their price target to $18. The move follows overwhelming shareholder approval for its acquisition by Kimberly-Clark and reflects concerns over limited upside and ongoing litigation risks.
As the NYSE and Nasdaq see a surge in 52-week extremes, we analyze four standout companies—two hitting new highs and two touching new lows—that offer compelling opportunities for patient investors looking toward 2026 and beyond.
The Washington Post has initiated a major restructuring, eliminating approximately one-third of its positions across all departments, including the closure of its sports desk and a reduction in international bureaus, as the newspaper grapples with financial pressures and shifting readership.
Amid a rapidly intensifying winter storm, a Gastonia Police K-9's tracking efforts proved critical in the safe recovery of a vulnerable 13-year-old boy who wandered from home.
Despite cooling national growth and pockets of weakness spreading across the Sunbelt, home prices increased in three-quarters of U.S. metro areas last quarter, as falling mortgage rates offered some relief to buyers.
UBS lowered its price target on Comcast (CMCSA) to $32, citing the company's ongoing transition in its broadband go-to-market approach. While some analysts see near-term pressure, others highlight the media giant's resilient cash flow and diversified segments.
Pfizer has announced positive Phase 2b results for its injectable obesity treatment, reporting significant weight reduction and a favorable safety profile as it gears up for a broad late-stage clinical program.
